This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Insulin » Research

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Insulin Glargine: Eight Years Later

Posted: Saturday, April 07, 2007

Insulin Glargine has become the most widely used insulin in the USA owing to its long duration of action without a pronounced peak. This introduction of a new form of insulin has made a dramatic effect on the ability of people to control their blood sugars. But is it being used properly? Should it be given once or twice a day?

Insulin Glargine Benefits Uncontrolled Type 2’s on Oral Meds Without Weight Gain

Posted: Thursday, January 18, 2007

Over 2000 type 2 patients lower their A1c 1.7 pts when insulin gargine is added to their oral therapy without weight gain.

Human Stem Cells Stimulate Insulin Production in Diabetic Mice

Posted: Thursday, November 16, 2006

Transplantation of human stromal cells into diabetic mice stimulated native mouse beta cells to produce insulin, and the human cells were taken up into the animals' glomerular epithelium.

Patients Miscode Monitors 16% of the Time Causing Faulty Readings

Posted: Thursday, November 16, 2006

When persons with diabetes use miscoded blood glucose meters to determine how much insulin to take, significant errors in insulin dose can result that may potentially lead to short- and long-term health complications.

Switch To Insulin Pen Improves Clinical Outcomes And Reduces Medical Costs

Posted: Thursday, November 02, 2006

Total all-cause annual treatment costs reduced by $1590 per patient.

Roche Diagnostics Announces Launch of ACCU-CHEK® Spirit Insulin Pump System

Posted: Thursday, October 19, 2006

New system provides more options for insulin pump users.

New DPP-4 and Glitazone Diabetes Drugs Will Account for 72% of the Diabetes Mark

Posted: Thursday, October 05, 2006

According to a new report from Decision Resources, the New Novel Drug Classes Will Account for 76% of the Type 2 Diabetes Market by 2020, even though they are not even available in the US at this time.

EASD Recommends Earlier Insulin Therapy, Don’t Wait 4-6 years!

Posted: Thursday, September 28, 2006

A Consensus Report launched at the annual meeting of the European Association for the Study of Diabetes, in Copenhagen, Denmark, is calling for urgent action to drastically improve the management of diabetes, particularly urging the increased acceptance of insulin. All patients with Type 2 diabetes, if they live long enough will require insulin.

Snuff It or Puff It: Rapid Acting Insulin Nasal Spray Begins New Study

Posted: Thursday, September 28, 2006

A new pharmacokinetic study to compare Nastech's intranasal insulin to injectable insulin and Exubera(R) (insulin human [rDNA origin]) Inhalation Powder, is set to begin.

Exubera Works Even with Cold or Flu-Study

Posted: Thursday, September 21, 2006

A new form of insulin which is inhaled rather than injected works even if patients have a respiratory infections or are exposed to passive cigarette smoke.